Trump’s Environmental Policies Could Threaten the Progress of Blue Economy ETFs
Impact of Trump's Policies on Blue Economy ETFs: Donald Trump's potential return to the White House and his plans to roll back pro-climate regulations could negatively affect blue economy exchange-traded funds (ETFs), particularly those focused on ocean-related companies. The KraneShares Rockefeller Ocean Engagement ETF (KSEA) is expected to be more resilient compared to others like IQ Clean Oceans ETF (OCEN) and Global X CleanTech ETF (CTEC).
Performance Outlook for KSEA: Analysts have a Moderate Buy consensus rating on KSEA, with strong performance indicators suggesting it can withstand unfavorable market conditions. The fund has shown a 12% rally over the past year, with an average price target indicating further upside potential.
Trade with 70% Backtested Accuracy
Analyst Views on WM
About WM
About the author

- Clean Harbors Financial Performance: In FY 2025, Clean Harbors reported nearly $6 billion in revenue, reflecting a 2.4% year-over-year growth, with a net income of approximately $391 million, demonstrating its profitability and stability in the complex hazardous waste management sector.
- Waste Management Expansion Strategy: Waste Management achieved $25.2 billion in revenue for FY 2025, a 14.2% increase, with a net income of about $2.7 billion, driven by organic growth and strategic integration of healthcare waste services, showcasing strong market demand and operational capabilities.
- Regulatory Risks and Challenges: Clean Harbors faces significant regulatory oversight, evidenced by a 2026 settlement with the U.S. EPA regarding its Safety-Kleen division, and manages approximately $230.7 million in environmental remediation liabilities, increasing operational risks.
- Market Competition and Investment Choices: Waste Management's acquisition of Stericycle in the medical waste sector presents growth potential but also integration challenges, while Clean Harbors relies on stricter EPA regulations for growth, requiring investors to choose based on their risk tolerance.
- Clean Harbors Financial Performance: In FY 2025, Clean Harbors reported nearly $6 billion in revenue, reflecting a 2.4% year-over-year growth, with a net income of approximately $391 million, demonstrating its profitability and stability in the complex hazardous waste management sector.
- Waste Management Expansion Strategy: Waste Management achieved $25.2 billion in revenue for FY 2025, a 14.2% increase, with a net income of about $2.7 billion, driven by its acquisition of Stericycle, which enhanced its competitive position in the market.
- Risk and Regulatory Challenges: Clean Harbors faces stringent oversight from the EPA and manages approximately $230.7 million in environmental remediation liabilities, while Waste Management navigates operational risks in integrating its Stericycle acquisition, requiring synchronization of billing and operational systems.
- Investor Choice Considerations: For investors seeking stable dividends, Waste Management may be the better option, while growth-focused investors might prefer Clean Harbors, particularly given the growth potential driven by new EPA regulations.
- Clean Harbors Performance: In FY 2025, Clean Harbors reported nearly $6 billion in revenue, reflecting a 2.4% increase, with a net income of approximately $391 million, demonstrating its profitability in the complex hazardous waste management sector.
- Waste Management Expansion: Waste Management achieved $25.2 billion in revenue for FY 2025, a 14.2% increase, with a net income of about $2.7 billion, driven by its strategic acquisition of Stericycle, enhancing its capabilities in medical waste disposal.
- Regulatory and Risk Challenges: Clean Harbors faces significant regulatory scrutiny from the EPA and manages approximately $230.7 million in environmental remediation liabilities, while Waste Management navigates the complexities of integrating Stericycle's operations.
- Valuation Comparison: Clean Harbors has a forward P/E ratio of 33.8x compared to Waste Management's 28.2x, indicating differing market valuations that investors should consider based on their risk tolerance and investment goals.
- Market Concentration Analysis: According to UBS, the market experienced strong gains in the first half of the year, primarily driven by a handful of megacap tech companies, leading to historically low correlations across stocks, indicating that investors are avoiding lower-risk companies, which has made many defensive stocks attractive in valuation.
- Valuation Gap in Defensive Stocks: Analyst Sean Burns highlighted that the gap between expensive and cheap defensive stocks is near the widest levels seen since 1990, nearly double the long-run average, with low-risk stocks trading at a market-implied yield of 4.4% compared to just 1.4% for high-risk stocks.
- Quality Defensive Stock Screening: UBS screened for defensive stocks with a market cap of at least $5 billion and a negative correlation to the S&P 500 over the past year, finding that these stocks not only exhibit low volatility but are also trading at discounts, all rated as buys by UBS.
- Individual Stock Performance Expectations: For instance, PepsiCo (PEP) is down about 6% year-to-date but is expected to report strong second-quarter earnings, with its North American food business recovering volume growth after price cuts; McDonald's (MCD) also beat first-quarter earnings expectations and is expected to continue gaining market share globally.
- Recession Probability: A J.P. Morgan study indicates a 35% chance of a global recession in 2026, with ongoing concerns about the Middle East and U.S. inflation, prompting investors to prepare for potential economic downturns.
- Kroger's Strong Performance: Kroger reported Q1 2026 revenue of $46.1 billion, up 2.2% year-over-year, with a notable 19% increase in e-commerce sales, demonstrating resilience during economic downturns, while offering a 2.5% dividend yield that attracts investors.
- UnitedHealth Group's Recovery: UnitedHealth Group's Q1 revenue reached $111.7 billion, a 2% increase from last year, and raised its full-year EPS outlook to $17.35, reflecting strong performance in the healthcare insurance market, with a dividend yield of 2.13%.
- WM's Steady Growth: WM's Q1 revenue was $6.22 billion, up 3.5% year-over-year, with EPS rising to $1.79, showcasing the stability of its waste management business amid economic fluctuations, and offering a dividend yield of 1.58%.
- Kroger's Market Share: Kroger holds an 8.6% market share in the U.S., second only to Walmart's 21.2%, with Q1 revenue reaching $46.1 billion, a 2.2% increase, highlighting the significance of its low-cost brands amid economic uncertainty.
- UnitedHealth's Performance Recovery: UnitedHealth reported Q1 revenues of $111.7 billion, up 2% year-over-year, and raised its full-year EPS outlook to $17.35, reflecting success in cost control and increased demand for healthcare services.
- WM's Stable Growth: WM achieved Q1 revenue of $6.22 billion, a 3.5% increase, while averaging 19,000 daily routes, demonstrating its ability to maintain stable cash flow and profitability during economic fluctuations.
- Recession-Proof Investment Choices: Despite Kroger's 7% stock decline this year, its 2.5% dividend yield and strong market position make it a preferred choice for recessionary investors, with UnitedHealth and WM also showing solid risk resilience.











